Sanofi’s venglustat succeeds in Phase 3 Gaucher trial but fails separate study in Fabry disease
赛诺菲的韦格鲁司他在Gaucher disease三期试验中告捷，但在另一项Fabry disease研究中失利

Sanofi’s investigational drug, with a track record of mixed results in the clinic, has passed a Phase 3 trial in Gaucher disease, but flunked a separate late-stage study in Fabry disease.
赛诺菲的一款在临床上表现喜忧参半的在研药物在Gaucher disease的三期试验中取得成功，但在Fabry disease的另一项后期研究中告败。